Administration of tirabrutinib suspension in a patient with primary central nervous system lymphoma: A case report.

Saved in:
Bibliographic Details
Title: Administration of tirabrutinib suspension in a patient with primary central nervous system lymphoma: A case report.
Authors: Yasu T; Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.; Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo 130-8575, Japan., Ohta H; Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo 204-8588, Japan., Gando Y; Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.; Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo 130-8575, Japan., Kobayashi M; Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo 130-8575, Japan.; Department of Hematology, Tokyo Metropolitan Bokutoh Hospital, Tokyo 130-8575, Japan.
Source: Oncology letters [Oncol Lett] 2026 Mar 17; Vol. 31 (5), pp. 176. Date of Electronic Publication: 2026 Mar 17 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: eCollection Cited Medium: Internet ISSN: 1792-1082 (Electronic) Linking ISSN: 17921074 NLM ISO Abbreviation: Oncol Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1792-1082
DOI:10.3892/ol.2026.15531